MedPath

The evaluation of Tragacanth on the treatment of constipation during pregnancy

Phase 2
Recruiting
Conditions
Constipation in pregnancy.
Constipation
K59.0
Registration Number
IRCT20140525017827N9
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
64
Inclusion Criteria

Pregnant patients with severe constipation
Homogeneous in terms of age, number of pregnancies, gestational age and .BMI

Exclusion Criteria

Sensitivity to Psyllium and Tragacanth
Have a history of kidney disease, thyroid and diabetes
Multi-fetal pregnancy
IBS or IBD patients
Patients developed with hemorrhoids

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ROMEII criteria defined constipation by having two or more of 4 main complains. Timepoint: Evaluation of severity of constipation and its scale before treatment and 1 week post treatment. Method of measurement: Constipation assessment scale.
Secondary Outcome Measures
NameTimeMethod
Improvement of quality of life. Timepoint: Quality of life at the beginning and end of treatment. Method of measurement: Quality of life sf_36 questionare.
© Copyright 2025. All Rights Reserved by MedPath